Up a level |
Stader, Felix, Courlet, Perrine, Kinvig, Hannah ORCID: 0000-0002-0061-1683, Penny, Melissa A, Decosterd, Laurent A, Battegay, Manuel, Siccardi, Marco ORCID: 0000-0002-3539-7867 and Marzolini, Catia
(2021)
Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug-Drug Interaction Magnitudes in the Elderly.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 109 (2).
pp. 471-484.
Thoueille, Paul ORCID: 0000-0002-2305-4277, Cavassini, Matthias ORCID: 0000-0003-0933-7833, Guidi, Monia ORCID: 0000-0002-6419-9317, Buclin, Thierry ORCID: 0000-0003-0639-5536, Girardin, François R, Decosterd, Laurent A ORCID: 0000-0002-9840-1325 and Marzolini, Catia ORCID: 0000-0002-2312-7050
(2024)
Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.
Open forum infectious diseases, 11 (2).
ofae023-.
Stader, Felix, Courlet, Perrine, Decosterd, Laurent A ORCID: 0000-0002-9840-1325, Battegay, Manuel and Marzolini, Catia ORCID: 0000-0002-2312-7050
(2021)
Physiologically-Based Pharmacokinetic Modeling Combined with Swiss HIV Cohort Study Data Supports No Dose Adjustment of Bictegravir in Elderly Individuals Living With HIV.
Clinical pharmacology and therapeutics, 109 (4).
pp. 1025-1029.
Thoueille, Paul, Alves Saldanha, Susana, Schaller, Fabian, Munting, Aline, Cavassini, Matthias, Braun, Dominique, Günthard, Huldrych F, Kusejko, Katharina, Surial, Bernard, Furrer, Hansjakob et al (show 11 more authors)
(2022)
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.
Pharmaceutics, 14 (8).
p. 1588.
Thoueille, Paul ORCID: 0000-0002-2305-4277, Saldanha, Susana Alves, Schaller, Fabian, Choong, Eva, Munting, Aline, Cavassini, Matthias ORCID: 0000-0003-0933-7833, Braun, Dominique, Günthard, Huldrych F, Kusejko, Katharina, Surial, Bernard ORCID: 0000-0002-1402-974X et al (show 17 more authors)
(2024)
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
The Lancet regional health. Europe, 36.
100793-.